Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,331,078
-
Total 13F shares
-
17,561,058
-
Share change
-
-154,892
-
Total reported value
-
$173,154,992
-
Price per share
-
$9.86
-
Number of holders
-
57
-
Value change
-
-$1,930,170
-
Number of buys
-
26
-
Number of sells
-
20
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q2 2019
As of 30 Jun 2019 Xenon Pharmaceuticals Inc. - Common Stock (XENE) had 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,561,058 shares of stock of the company.
Largest 10 holders included Avoro Capital Advisors LLC, BVF INC/IL, Vivo Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., EVENTIDE ASSET MANAGEMENT, LLC, Capital International Investors, Capital World Investors, Aquilo Capital Management, LLC, Point72 Asset Management, L.P., and ACUTA CAPITAL PARTNERS, LLC.
This table shows 57 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.